news
HIV vaccine hurdle cleared
An international team of researchers have demonstrated a way of overcoming one of the major stumbling blocks that has prevented the development of a vaccine against HIV..
List view / Grid view
Vaccine
news
Researchers identify possible treatments for deadly diseases affecting children
Researchers have identified four pathogens that are responsible for the vast majority of diarrheal illnesses - leading the way for potential new treatments...
news
New metabolic target in quest to control immune response
Immune cells could help to increase immune activity in vaccines or suppress immune reactions in autoimmune diseases...
news
New synthetic polio vaccine candidate
A collaborative team of scientists have developed a novel synthetic vaccine with a method grown in plants that uses virus-like particles...
news
Dartmouth tuberculosis vaccine passes important milestone
Investigators at Dartmouth's Geisel School of Medicine announced that two new studies of DAR-901, their investigational vaccine against tuberculosis (TB), have moved it to the forefront of new vaccines in development for global control of this deadly infectious disease.
news
Researchers identify potential Zika Virus target
New research provides insights into why infection with Zika virus after birth generally causes only mild symptoms, whereas devastating foetal malformations can develop when infection occurs during pregnancy.
news
Microdermics closes $1 Million funding to replace hypodermic needles
Microdermics has completed its $1 million financing round, which was oversubscribed and received robust global interest.
news
New meningitis bacteria research could hold key to developing improved vaccines
Meningococcal infections are the most common cause of bacterial meningitis in the United Kingdom, a life-threatening disease that poses a continuing threat worldwide. With growing fears around the increase of antibiotic-resistant bacteria, understanding why certain strains don't respond to vaccines could prove vital in helping reduce the number of global…
article
Drug Target Review – Issue #1 2017
Included in this issue: Importance of building patient trust; Vaccines & Immunology; Oncology; Assays; Biomarkers; and Antibodies...
news
Kymab receives $9m R+D grant from Bill & Melinda Gates Foundation
The monoclonal antibody biopharmaceutical group Kymab announced today that it has received a $9m grant from the Bill & Melinda Gates Foundation to accelerate the development of novel vaccines and therapeutics for infectious diseases, including HIV.
news
Scientists identify 7 proteins that make Zika so deadly
A new study by scientists at the University of Maryland School of Medicine have identified seven key proteins in the virus that may be the culprits behind its damaging effects.
article
Versatile applications of next-generation sequencing in pharmaceutics
Next-generation sequencing (NGS) technologies hold great promise for unravelling the mysteries of biological systems, with the advent of DNA sequencing methods having greatly accelerated biomedical research, gaining broad applicability in disease diagnosis and therapeutics in recent years...
news
TSRI scientists develop vaccine against fatal prescription opioid overdose
30 November 2016 | By Niamh Louise Marriott, Digital Editor
Scientists at The Scripps Research Institute have developed a vaccine that blocks the pain-numbing effects of the opioid drugs in animal models...
news
Artes and BioSun to co-develop on HPV vaccine
4 November 2016 | By Niamh Louise Marriott, Digital Content Producer
The agreed long-term collaboration will take strengths from both companies to collaborate on the HPV vaccine although financial details of this agreement...
news
Immunological memory of the mucosa: a breakthrough in vaccine research
16 September 2016 | By Niamh Louise Marriott, Digital Content Producer
The mucosa forms a unique immunological antibody memory that does not occur if the vaccine is given by injection, says a study from Sahlgrenska Academy...
